Amerigen Pharmaceuticals President and CEO to Present a Company Overview at the J.P. Morgan Healthcare Conference

EAST BRUNSWICK, N.J., Jan. 5, 2012 /PRNewswire/ -- Amerigen Pharmaceuticals announced today that John Lowry, Amerigen's President & CEO, will present an overview of the company at the 30th Annual J.P. Morgan Healthcare Conference at the Westin St. Francis in San Francisco on Wednesday, January 11th, 2012 at 4:00 p.m. Pacific Time / 7:00 p.m. Eastern Time.

About Amerigen

Amerigen Pharmaceuticals is a group of companies engaged in all phases of the generic pharmaceutical business, with operations in the U.S. and China. The group is controlled by Amerigen Pharmaceuticals Limited. The U.S. regulatory and commercial activities within the group are conducted by Amerigen Pharmaceuticals Inc., based in East Brunswick, NJ, U.S.A. The group's

Chinese subsidiary, Suzhou Amerigen Pharmaceuticals Limited, is located in Suzhou, Jiangsu Province. The group has an active portfolio of products under development, filed, or intended for filing, as ANDA's with the US FDA and the Chinese SFDA. Amerigen's focus is orally delivered products that are challenging to develop, require specialized technologies or high containment to manufacture, and present complex regulatory and intellectual property obstacles to bring to market. All of Amerigen's products are developed and manufactured by the company or its partners around the world to meet the highest quality standards, including the U.S. FDA.

SOURCE Amerigen Pharmaceuticals